RGT 4.88% 43.0¢ argent biopharma limited

MXC Pros and Cons, page-40

  1. 5,410 Posts.
    lightbulb Created with Sketch. 542
    With respect, it's a pretty memorable piece of news, so when people say that it's a dud and haughtily ask about details as though it's all bs, then credibility is going to suffer. It's not just a matter of bruised egos and not wanting to accept bad news. Anyone with an interest in MXC, holder or non holder, believer or sceptic, should take 10 minutes to read every word of the Panax deal and not make fiery rhetorical statements about details that are written in plain English, straight from the horse's mouth.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.